3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Nasopharyngeal Carcinoma
3
Leukemia, Myeloid, Acute
3
Squamous Cell Carcinoma of Head and Neck
2
Myelodysplastic Syndromes
2
Carcinoma, Non-Small-Cell Lung
2
Turcot syndrome
1
Tongue Neoplasms
1
Thrombocythemia, Essential
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Nasopharyngeal Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Esophagitis
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
ESCC
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
Oxaliplatin
146
Fluorouracil
137
Capecitabine
122
Leucovorin
106
Irinotecan
85
Radiotherapy
67
Bevacizumab
64
Cetuximab
46
Folfox protocol
28
Surgical Procedures, Operative
23
Radiation
23
Drug Therapy
22
Panitumumab
19
XELOX
18
Chemotherapy, Adjuvant
15
Neoadjuvant Therapy
14
Radiotherapy, Intensity-Modulated
13
Chemoradiotherapy
13
Magnetic Resonance Spectroscopy
11
regorafenib
10
Nivolumab
10
Floxuridine
10
sintilimab
8
raltitrexed
8
Specimen Handling
8
IFL protocol
8
Celecoxib
8
Biopsy
8
trifluridine tipiracil drug combination
7
tislelizumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Rectal Neoplasms
×
Induction Chemotherapy
×
Clear all
NCT05054959
2021-09-23
ICONA
Institute of Oncology Ljubljana
Phase 2
Recruiting
62 enrolled